Medisurge Bio Health Profile
Key Indicators
- Authorised Capital ₹ 0.45 M
as on 08-04-2024
- Paid Up Capital ₹ 0.45 M
as on 08-04-2024
- Company Age 12 Year, 1 Month
- Last Filing with ROC 31 Mar 2017
- Revenue %
(FY 2017)
- Profit -32.62%
(FY 2017)
- Ebitda -32.62%
(FY 2017)
- Net Worth -64.11%
(FY 2017)
- Total Assets -64.11%
(FY 2017)
About Medisurge Bio Health
- CIN/LLPIN
U52310KL2012PTC032840
- Company No.
032840
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Dec 2012
- Date of AGM
30 Sep 2017
- Date of Balance Sheet
31 Mar 2017
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Company Details
- Location
Thrissur, Kerala, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Medisurge Bio Health?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kottattil Noushad  | Managing Director | 05-Dec-2012 | Current |
Board Members(8)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Afsal Salu | Director | 05-Dec-2012 | Current |
| Parayil Abdulrazak | Director | 05-Dec-2012 | Current |
| Mohamed Naduvanchery | Director | 05-Dec-2012 | Current |
| Ali Moidunny | Director | 05-Dec-2012 | Current |
| Azeez Aneefa | Director | 05-Dec-2012 | Current |
| Neduvanchery Mohamedshamsudheen | Director | 05-Dec-2012 | Current |
Financial Performance of Medisurge Bio Health.
Medisurge Bio Health Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 32.62% decrease in profit. The company's net worth observed a substantial decline by a decrease of 64.11%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Medisurge Bio Health?
In 2017, Medisurge Bio Health had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Daya General Hospital LimitedActive 47 years 11 monthsParayil Abdulrazak, Valiakath Abdulazeez and 1 more are mutual person
Donn Builders And Developers Private LimitedActive 16 years 7 monthsParayil Abdulrazak is a mutual person
- Kozhikode Daya Hospitals Private LimitedActive 14 years 11 months
Parayil Abdulrazak, Mohamed Naduvanchery and 1 more are mutual person
- Ishal Gazal Trading Corporation Private LimitedActive 1 year 5 months
Ali Moidunny and Valiakath Abdulazeez are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Medisurge Bio Health?
Unlock and access historical data on people associated with Medisurge Bio Health, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medisurge Bio Health, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medisurge Bio Health's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
